Could A Gilead Sciences' Next-Generation Asset Be The Key To Bullish Analyst Upgrade? - Gilead Sciences (NASDAQ:GILD)

Shares of Gilead Sciences, Inc. (NASDAQ: GILD) are trading higher into Friday’s trading session after Bank of America Securities upgraded the stock, highlighting an underappreciated growth potential in its core HIV business and emerging hem

Related Keywords

United States ,America ,Geoff Meacham ,Gilead Sciences ,Gilead Sciences Inc ,America Securities ,Kidney Care ,